B-Lite轻量乳房假体初次隆乳中长期结局:前瞻性多中心上市后随访研究
该多中心前瞻性单臂上市后随访研究纳入101例接受双侧初次隆乳的女性,评估B-Lite轻量假体的临床性能、安全性、满意度及生活质量。12个月时92%患者实现至少一个罩杯增加,无Baker III/IV包膜挛缩、破裂或BIA-ALCL发生,患者满意度98.6%且无后悔,Kaplan-Meier再手术风险1年6.9%、5年9.9%。
要点
- B-Lite假体初次隆乳12个月至少一个罩杯增加达92%(95%CI 84%-97%)。
- 无Baker III/IV包膜挛缩、破裂或BIA-ALCL发生,最常见不良事件为暂时性感觉改变(8.9%)。
- 患者满意度98.6%且0%后悔,再手术风险5年9.9%。
核心结论
- B-Lite轻量假体在3至5年随访中显示出高效性、极高满意度和良好安全性。
研究设计与样本
- 多中心、前瞻性、单臂、厂商资助的上市后临床随访研究,纳入101例18-60岁接受双侧初次乳房增大术的女性。
主要发现
- 12个月时92%(95%CI 84%-97%)患者实现至少一个罩杯增加。
- 无Baker III/IV包膜挛缩、破裂或BIA-ALCL发生。
- 最常见不良事件为暂时性感觉改变(8.9%),其他不良事件不常见且主要与手术相关。
- Kaplan-Meier再手术风险1年为6.9%,5年为9.9%。
- 患者满意度平均98.6%,0%后悔;医生满意或非常满意为97%至100%。
临床怎么用
- B-Lite轻量假体可作为初次隆乳的一种选择,其3至5年随访显示高罩杯增加率、高满意度和低包膜挛缩/破裂风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lightweight breast implants (B-Lite) integrate air-filled microspheres into silicone gel to reduce implant weight by up to 30% while maintaining volume and mechanical properties. Long-term prospective data in primary augmentation remain limited. OBJECTIVES: To evaluate clinical performance, safety, satisfaction, and quality of life (QoL) outcomes following primary augmentation with B-Lite implants. METHODS: This multicenter, prospective, single-arm manufacturer-sponsored postmarketing clinical follow-up (PMCF) study enrolled genetically female patients (18-60 years) undergoing bilateral primary breast augmentation. Implants (round or anatomical; POLYsmoooth, POLYtxt, MESMO, or Microthane; 200-755 cc) were placed through inframammary incisions using a standardized technique. The primary endpoint was ≥1 bra-cup increase at 12 months; secondary endpoints included QoL (Body Esteem, Rosenberg, shortened Tennessee, RAND SF-36), satisfaction, and adverse events (AEs) such as capsular contracture (Baker III-IV), rupture, breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and reoperation. RESULTS: In all, 101 patients (mean age 32.7 ± 8.0 years; BMI 20.9 ± 1.8) underwent augmentation. At 12 months, ≥1-cup increase occurred in 92% (95% CI, 84%-97%). No Baker III/IV contracture, rupture, or BIA-ALCL occurred. The most frequent AE was transient sensory change (8.9%); others were infrequent and mainly procedure related. Kaplan-Meier reoperation risk was 6.9% at 1 year and 9.9% at 5 years. Patient satisfaction averaged 98.6% with 0% regret; surgeons were satisfied or very satisfied at 97% to 100%. QoL showed durable gains in Body Esteem-sexual attractiveness and Rosenberg; SF-36 composites remained stable. CONCLUSIONS: Lightweight B-Lite implants showed high effectiveness, very high satisfaction, and a favorable safety profile through 3 to 5 years. LEVEL OF EVIDENCE: 2: For image description, please refer to the figure legend and surrounding text.
引用
- Reichenberger M, Hedén P, Germann G, et al. Mid- to Long-term Outcomes Following Primary Augmentation With B-Lite Lightweight Breast Implants: A Prospective Multicenter Postmarketing Clinical Follow-up Study. Aesthet Surg J. 2026. PMID: 42517198. doi:10.1093/asj/sjag105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。